114 related articles for article (PubMed ID: 9648520)
21. Antineoplastic and Cytotoxic Activities of Nickel(II) Complexes of Thiosemicarbazones.
Hall IH; Miller MC; West DX
Met Based Drugs; 1997; 4(2):89-95. PubMed ID: 18475774
[TBL] [Abstract][Full Text] [Related]
22. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
23. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Holden SA; Teicher BA; Robinson MF; Northey D; Rosowsky A
Cancer Chemother Pharmacol; 1995; 36(2):165-71. PubMed ID: 7767954
[TBL] [Abstract][Full Text] [Related]
24. The cytotoxicity of N-substituted diphenimides and 6,7-dihydro-5H-dibenz[c,e]azepines.
Hall IH; Wong OT; Chi LK
Anticancer Drugs; 1993 Dec; 4(6):665-70. PubMed ID: 8298166
[TBL] [Abstract][Full Text] [Related]
25. Substituted 4-hydroxyproline di- and tri-peptides as cytotoxic agents.
Hall IH; Chen SY
Amino Acids; 1999; 16(1):79-89. PubMed ID: 10078336
[TBL] [Abstract][Full Text] [Related]
26. Antitumor agents. 124. New 4 beta-substituted aniline derivatives of 6,7-O,O-demethylene-4'-O-demethylpodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.
Wang ZQ; Hu H; Chen HX; Cheng YC; Lee KH
J Med Chem; 1992 Mar; 35(5):871-7. PubMed ID: 1312601
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of topoisomerase II by a novel antitumor cyclic depsipeptide, BE-22179.
Yoshinari T; Okada H; Yamada A; Uemura D; Oka H; Suda H; Okura A
Jpn J Cancer Res; 1994 May; 85(5):550-5. PubMed ID: 8014113
[TBL] [Abstract][Full Text] [Related]
29. F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
Etiévant C; Kruczynski A; Barret JM; Perrin D; van Hille B; Guminski Y; Hill BT
Cancer Chemother Pharmacol; 2000; 46(2):101-13. PubMed ID: 10972479
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic and cytogenetic effects of complexes of Pd (II) with 4N-substituted derivatives of 2-acetyl-pyridine-thiosemicarbazone.
Papageorgiou A; Iakovidou Z; Mourelatos D; Mioglou E; Boutis L; Kotsis A; Kovala-Demertzi D; Domopoulou A; West DX; Dermetzis MA
Anticancer Res; 1997; 17(1A):247-51. PubMed ID: 9066660
[TBL] [Abstract][Full Text] [Related]
31. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Kaufmann SH
Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues.
Pastwa E; Ciesielska E; Piestrzeniewicz MK; Denny WA; Gniazdowski M; Szmigiero L
Biochem Pharmacol; 1998 Aug; 56(3):351-9. PubMed ID: 9744573
[TBL] [Abstract][Full Text] [Related]
33. Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.
Solary E; Leteurtre F; Paull KD; Scudiero D; Hamel E; Pommier Y
Biochem Pharmacol; 1993 Jun; 45(12):2449-56. PubMed ID: 8392342
[TBL] [Abstract][Full Text] [Related]
34. Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα.
Wilson JT; Jiang X; McGill BC; Lisic EC; Deweese JE
Chem Res Toxicol; 2016 Apr; 29(4):649-58. PubMed ID: 26982206
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
36. Quinoline-2-carboxaldehyde thiosemicarbazones and their Cu(II) and Ni(II) complexes as topoisomerase IIa inhibitors.
Bisceglie F; Musiari A; Pinelli S; Alinovi R; Menozzi I; Polverini E; Tarasconi P; Tavone M; Pelosi G
J Inorg Biochem; 2015 Nov; 152():10-9. PubMed ID: 26335598
[TBL] [Abstract][Full Text] [Related]
37. The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells.
Hall IH; Izydore R; Hall ES; Miller MC; Daniels DL; Debnath ML; Woodard T
Anticancer Drugs; 1992 Jun; 3(3):273-80. PubMed ID: 1525409
[TBL] [Abstract][Full Text] [Related]
38. Effect of 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants.
Chang JY; Han FS; Liu SY; Wang ZQ; Lee KH; Cheng YC
Cancer Res; 1991 Apr; 51(7):1755-9. PubMed ID: 1848478
[TBL] [Abstract][Full Text] [Related]
39. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
Han S; Xiao Z; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
[TBL] [Abstract][Full Text] [Related]
40. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
